PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 5354 (111th)

GEDI Act

referredUnited States· United States Congress· EN

Introduced

20 May 2010

Last action

—

Status

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sponsors

—

Subjects

Discovery layer

Source updated

5 December 2025

Official sourceDownload fileView documentsShare

Summary

Gestational Diabetes Act of 2009 [ sic ] or the GEDI Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to convene a Research Advisory Committee. Requires the Director, in consultation with the Research Advisory Committee, to develop a multisite, gestational diabetes research project within the CDC's diabetes program to expand and enhance surveillance data and public health research on gestational diabetes. Requires the Secretary, acting through the Director, to award grants to nonprofit organizations or state or local health agencies for demonstration projects that build capacity with key stakeholders, build new surveillance systems, and implement and evaluate evidence-based interventions to reduce the incidence of gestational diabetes and its recurrence and to prevent type 2 diabetes after pregnancy. Requires the Director to conduct and support public health research regarding gestational diabetes, which research shall include: (1) developing and testing novel approaches for improving postpartum diabetes testing or screening and for preventing type 2 diabetes in women with a history of gestational diabetes; and (2) conducting research to further understanding of the epidemiologic, socioenvironmental, behavioral, translation, and biomedical factors and health systems that influence risk of gestational diabetes and progression to type 2 diabetes. Requires the Director to encourage postpartum screenings after gestational diabetes within the state-based diabetes prevention and control programs to reduce the incidence of gestational diabetes and its recurrence, progression to type 2 diabetes, and its related complications.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

10 official files

Referred in Senate (text)

View fileDownload file

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.